Results 51 to 60 of about 48,974 (212)
Survival analysis of patients with HNSCC.
, 2012 A) Kaplan-Meier curve analysis illustrating a worse overall survival for HNSCC patients with detectable Ano1 protein expression (solid line: Ano1 protein negative, dashed line: Ano1 protein positive).
Karl Kunzelmann (80303) +10 more
core +1 more source
Medical Gas Plasma Treatment in Head and Neck Cancer—Challenges and Opportunities
Applied Sciences, 2020 Despite progress in oncotherapy, cancer is still among the deadliest diseases in the Western world, emphasizing the demand for novel treatment avenues.
Julia Berner +6 more
doaj +1 more source
Cells, 2019 Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide and often has a poor prognosis. The present study investigated the role of the low affinity nerve growth factor receptor CD271 as a putative therapy target in HNSCC ...
Yannick Foerster +7 more
doaj +1 more source
OncoImmunology, 2020 The molecular cargo of tumor-cell-derived exosomes (TEX) mimics that of parental tumor cells. Thus, TEX could potentially serve as noninvasive biomarkers of cancer progression.
Marie-Nicole Theodoraki +4 more
doaj +1 more source
Roles of E2F family members in the diagnosis and prognosis of head and neck squamous cell carcinoma
BMC Medical Genomics, 2023 Background Head and neck squamous cell carcinoma (HNSCC) is the sixth most prevalent cancer worldwide. E2Fs are a group of transcription factors involved in the carcinogenesis and progression of various cancers. However, the exact roles of each member of
Yaoxu Li +3 more
doaj +1 more source
Patients’ HNSCC information from three hospitals.
, 2019 Patients’ HNSCC information from three hospitals.
Zaizai Cao (7418657) +17 more
core +1 more source
T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma
OncoImmunology, 2017 Head and neck squamous cell carcinoma (HNSCC) is one of the most diffused cancer types, characterized by a high reoccurrence rate, mainly due to the inability of current therapeutic approaches to completely eradicate cancer cells.
Daniele Maggioni +2 more
doaj +1 more source
Top 15 dark HNSCC mutation-enriched pathways.
, 2019 Top 15 dark HNSCC mutation-enriched pathways.
Shannon K. McWeeney (226756) +15 more
core +1 more source
Abelson Kinase Based Regulation of Tumor Cell Invasion in HNSCC [PDF]
, 2013 Nearly 40,000 new cases of head and neck squamous cell carcinoma (HNSCC) are annually diagnosed in the United States. The current standard of care for HNSCC patients consists of chemoradiation often combined with targeted therapeutic agents. However, the
Hayes, Karen E.
core +1 more source
Epigenetics, 2020 CTLA-4 blocking therapeutic antibodies are currently under investigation in head and neck squamous cell carcinoma (HNSCC). A better understanding of the epigenetic regulation of the CD28 superfamily members CD28, CTLA-4, and ICOS and their B7 ligands ...
Luka de Vos +9 more
doaj +1 more source